comparemela.com

Latest Breaking News On - Hhlr advisors - Page 14 : comparemela.com

Li Auto (NASDAQ:LI) Rating Lowered to Hold at Zacks Investment Research

Li Auto (NASDAQ:LI – Get Rating) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a report released on Thursday, Zacks.com reports. According to Zacks, “Li Auto Inc. is an innovator in energy vehicle market. The Company designs, develops, manufactures, and sells premium smart electric SUVs. Li Auto Inc. […]

Legend Biotech (NASDAQ:LEGN) Stock Rating Lowered by Zacks Investment Research

Legend Biotech (NASDAQ:LEGN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. […]

Futu (NASDAQ:FUTU) Stock Rating Lowered by Zacks Investment Research

Futu (NASDAQ:FUTU – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Futu Holdings Limited is a technology company which offers a digitized brokerage platform. It is primarily engaged in the online brokerage […]

JD com (NASDAQ:JD) Downgraded to Sell at StockNews com

StockNews.com cut shares of JD.com (NASDAQ:JD – Get Rating) from a hold rating to a sell rating in a report published on Wednesday. Other equities analysts have also recently issued research reports about the company. CLSA lowered their price target on JD.com from $108.00 to $100.00 in a report on Wednesday, April 13th. Mizuho lowered […]

$0 02 EPS Expected for Enfusion, Inc (NYSE:ENFN) This Quarter

Brokerages forecast that Enfusion, Inc. (NYSE:ENFN – Get Rating) will announce earnings per share (EPS) of $0.02 for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Enfusion’s earnings, with the lowest EPS estimate coming in at $0.02 and the highest estimate coming in at $0.03. The business is scheduled to […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.